MFDS
- Status: likely_approved
🇰🇷 Brexafemme in South Korea
Brexafemme (IBREXAFUNGERP) regulatory status in South Korea.
Marketing authorisation
Brexafemme in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Brexafemme approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Brexafemme in South Korea?
GSK is the originator. The local marketing authorisation holder may differ — check the official source linked above.